MARLTON, N.J., April 28, 2016 /PRNewswire/ -- Acsis, a leading provider of supply chain serialization solutions, today announced that leading IT market research and advisory firm IDC has named it a "Major Player" in the IDC MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor Assessment (doc # US40511116, March 2016). The report provides an assessment of the capabilities and business strategies of 10 vendors in the pharmaceutical track and trace software market.
"Deadlines for serialization and tracking of pharmaceutical products are coming up rapidly. Track and trace software vendors are reacting with new products, capabilities, and support models to meet this growing market. Pharmaceutical companies must diligently vet these companies and solutions to find the best long-term match to meet the needs of their companies and supply chain partners."
– Mike Townsend, Research Manager, IDC Health Insights' Commercial Life Sciences
Acsis' 20-year history of bringing traceability to complex supply chains around the world has yielded a deep expertise in understanding and automating data collection requirements in the core flows of tracking, tracing, serializing and labeling products. Acsis Edge for Pharma delivers serialization control for all warehouse activities by capturing movements and data as a product moves from receipt through distribution. As a lightweight, quick-to-implement solution, Acsis Edge for Pharma eliminates the costs, delay and limited value of custom development for faster DSCSA compliance. A seamless execution view, which integrates with both ERP and EPCIS, improves productivity and provides a foundation for continuing value through tighter returns and recall processes.
"It's exciting to be a key part of such a critical time for traceability in the pharma industry. Being named a 'Major Player' by the IDC MarketScape reaffirms our goal of providing customers the best of both worlds: a rapid serialization implementation for immediate DSCSA compliance and a platform that will allow them to scale and exploit operational value later."
– Jeremy Coote, CEO, Acsis, Inc.
Follow Acsis on Twitter: https://twitter.com/acsisinc
About IDC MarketScape
IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor's position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360 degree assessment of the strengths and weaknesses of current and prospective vendors.
For over 20 years, Acsis has provided warehouse execution systems for Fortune 500 pharmaceutical companies. With our Acsis Edge solution, companies ensure compliance with the Drug Supply Chain Security Act and other serialization mandates, while leveraging their serialization data to increase productivity, improve order accuracy, and build a foundation for returns, chargebacks and recall management.
Acsis is headquartered in Marlton, NJ. Customers include AbbVie, Amerisource Bergen, Ashland, Cintas, DuPont, Glatfelter, Hershey's, Meda and OSRAM. www.acsisinc.com
Acsis and Acsis Edge are trademarks or registered trademarks of Acsis Inc. Other company names, product names and company logos mentioned herein are the trademarks, or registered trademarks of their respective owners.
Contact: Estera Hayes, Full Circle Communications
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/idc-marketscape-names-acsis-a-major-player-in-the-pharmaceutical-track-and-trace-software-market-300259006.html
SOURCE Acsis Inc.